Cargando…

Caffeine boosts Ataluren's readthrough activity

The readthrough of nonsense mutations by small molecules like Ataluren is considered a novel therapeutic approach to overcome the gene defect in several genetic diseases as cystic fibrosis (CF). This pharmacological approach suppresses translation termination at premature termination codons (PTCs re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lentini, Laura, Melfi, Raffaella, Cancemi, Patrizia, Pibiri, Ivana, Di Leonardo, Aldo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595402/ https://www.ncbi.nlm.nih.gov/pubmed/31294114 http://dx.doi.org/10.1016/j.heliyon.2019.e01963

Ejemplares similares

Toward a Rationale for the PTC124 (Ataluren) Promoted Readthrough of Premature Stop Codons: A Computational Approach and GFP-Reporter Cell-Based Assay
por: Lentini, Laura, et al.
Publicado: (2014)

Strategies against Nonsense: Oxadiazoles as Translational Readthrough-Inducing Drugs (TRIDs)
por: Campofelice, Ambra, et al.
Publicado: (2019)

Readthrough Approach Using NV Translational Readthrough-Inducing Drugs (TRIDs): A Study of the Possible Off-Target Effects on Natural Termination Codons (NTCs) on TP53 and Housekeeping Gene Expression
por: Perriera, Riccardo, et al.
Publicado: (2023)

Investigating the Inhibition of FTSJ1, a Tryptophan tRNA-Specific 2′-O-Methyltransferase by NV TRIDs, as a Mechanism of Readthrough in Nonsense Mutated CFTR
por: Carollo, Pietro Salvatore, et al.
Publicado: (2023)

Ataluren—Promising Therapeutic Premature Termination Codon Readthrough Frontrunner
por: Michorowska, Sylwia
Publicado: (2021)

Targeting Nonsense: Optimization of 1,2,4-Oxadiazole TRIDs to Rescue CFTR Expression and Functionality in Cystic Fibrosis Cell Model Systems
por: Pibiri, Ivana, et al.
Publicado: (2020)

Investigating REPAIRv2 as a Tool to Edit CFTR mRNA with Premature Stop Codons
por: Melfi, Raffaella, et al.
Publicado: (2020)

Site-Specific RNA Editing of Stop Mutations in the CFTR mRNA of Human Bronchial Cultured Cells
por: Chiavetta, Roberta F., et al.
Publicado: (2023)

Effect of Ataluren on dystrophin mutations
por: Berger, Joachim, et al.
Publicado: (2020)

Treatment with Ataluren for Duchene Muscular Dystrophy
por: Morkous, Sameh S.
Publicado: (2020)

Ataluren Pharmacokinetics in Healthy Japanese and Caucasian Subjects
por: Kong, Ronald, et al.
Publicado: (2019)

Ataluren treatment of patients with nonsense mutation dystrophinopathy
por: Bushby, Katharine, et al.
Publicado: (2014)

Mononuclear Perfluoroalkyl-Heterocyclic Complexes of Pd(II): Synthesis, Structural Characterization and Antimicrobial Activity
por: Rubino, Simona, et al.
Publicado: (2020)

Long term treatment with ataluren—the Swedish experience
por: Michael, Eva, et al.
Publicado: (2021)

Clinical potential of ataluren in the treatment of Duchenne muscular dystrophy
por: Namgoong, John Hyun, et al.
Publicado: (2016)

Heterologous Stop Codon Readthrough of Metazoan Readthrough Candidates in Yeast
por: Chan, Clara S., et al.
Publicado: (2013)

Formulation and Stability of Ataluren Eye Drop Oily Solution for Aniridia
por: Djayet, Celia, et al.
Publicado: (2020)

Ataluren for the Treatment of Usher Syndrome 2A Caused by Nonsense Mutations
por: Samanta, Ananya, et al.
Publicado: (2019)

Ataluren and aminoglycosides stimulate read-through of nonsense codons by orthogonal mechanisms
por: Ng, Martin Y., et al.
Publicado: (2021)

Ribosomal frameshifting, jumping and readthrough
por: Weiss, Robert B.
Publicado: (1991)

Ataluren suppresses a premature termination codon in an MPS I-H mouse
por: Wang, Dan, et al.
Publicado: (2022)

Yeast applied readthrough inducing system (YARIS): an invivo assay for the comprehensive study of translational readthrough
por: Beznosková, Petra, et al.
Publicado: (2019)

In vitro metabolism, reaction phenotyping, enzyme kinetics, CYP inhibition and induction potential of ataluren
por: Kong, Ronald, et al.
Publicado: (2020)

Cellular senescence limits translational readthrough
por: del Toro, Neylen, et al.
Publicado: (2021)

ARTDeco: automatic readthrough transcription detection
por: Roth, Samuel J., et al.
Publicado: (2020)

Aminoglycosides, but not PTC124 (Ataluren), rescue nonsense mutations in the leptin receptor and in luciferase reporter genes
por: Bolze, Florian, et al.
Publicado: (2017)

Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients
por: McDonald, Craig M, et al.
Publicado: (2021)

Nonaminoglycoside compounds induce readthrough of nonsense mutations
por: Du, Liutao, et al.
Publicado: (2009)

Transcriptional Readthrough Interrupts Boundary Function in Drosophila
por: Kyrchanova, Olga, et al.
Publicado: (2023)

Readthrough Acetylcholinesterase Is Increased in Human Liver Cirrhosis
por: García-Ayllón, María-Salud, et al.
Publicado: (2012)

Early treatment with Ataluren of a 2-year-old boy with nonsense mutation Duchenne dystrophy
por: Bitetti, Ilaria, et al.
Publicado: (2021)

Ataluren binds to multiple protein synthesis apparatus sites and competitively inhibits release factor-dependent termination
por: Huang, Shijie, et al.
Publicado: (2022)

Evolutionary Dynamics of Abundant Stop Codon Readthrough
por: Jungreis, Irwin, et al.
Publicado: (2016)

Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study
por: Mercuri, Eugenio, et al.
Publicado: (2020)

Ataluren for drug‐resistant epilepsy in nonsense variant‐mediated Dravet syndrome and CDKL5 deficiency disorder
por: Devinsky, Orrin, et al.
Publicado: (2021)

Identification of stop codon readthrough genes in Saccharomyces cerevisiae
por: Namy, Olivier, et al.
Publicado: (2003)

RNA pseudoknots: Translational frameshifting and readthrough on viral RNAs
por: Ten Dam, Edwin B., et al.
Publicado: (1990)

Variable readthrough responsiveness of nonsense mutations in hemophilia A
por: Martorell, Lluis, et al.
Publicado: (2020)

Stop Codon Context-Specific Induction of Translational Readthrough
por: Schilff, Mirco, et al.
Publicado: (2021)

Evaluation of gliovascular functions of Aqp4 readthrough isoforms
por: Mueller, Shayna M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a3sjpjk8nsebd2dmu2lk9svap8